Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 May 1;101(9):1916–1922. doi: 10.1172/JCI1530

Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase.

D E Vatner 1, K Asai 1, M Iwase 1, Y Ishikawa 1, T E Wagner 1, R P Shannon 1, C J Homcy 1, S F Vatner 1
PMCID: PMC508778  PMID: 9576756

Abstract

Inotropic and chronotropic responses to catecholamines in young adult transgenic mice overexpressing myocardial Gsalpha are enhanced. One might predict that over the life of the animal, this chronically enhanced beta-adrenergic receptor stimulation would result in homologous catecholamine desensitization. To test this hypothesis, old transgenic Gsalpha mice and age-matched controls were studied physiologically in terms of responsiveness of left ventricular function (ejection fraction) to isoproterenol in vivo and in vitro in terms of beta-adrenergic receptor signaling. Old transgenic mice still responded to isoproterenol with augmented (P < 0.05) left ventricular ejection fraction (+44+/-3%) compared with age-matched controls (+24+/-1%). Although total beta-adrenergic receptor density was reduced in the old transgenic mice, and G protein receptor kinase 2 (beta-adrenergic receptor kinase) levels were increased, the fraction of receptors binding agonist with high affinity as well as isoproterenol- and G protein-stimulated adenylyl cyclase activities were enhanced. Thus, classical catecholamine desensitization is not effective in attenuation of persistently enhanced responses to sympathetic stimulation in mice overexpressing myocardial Gsalpha. To support this conclusion further, experiments were performed with chronic isoproterenol, which elicited effective desensitization in wild-type controls, but failed to elicit desensitization in overexpressed Gsalpha mice. The results of this study suggest that the lack of protective desensitization mechanisms may be responsible in part for the dilated cardiomyopathy which develops with chronic sympathetic stress over the life of these animals.

Full Text

The Full Text of this article is available as a PDF (226.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  2. Bristow M. R., Ginsburg R., Minobe W., Cubicciotti R. S., Sageman W. S., Lurie K., Billingham M. E., Harrison D. C., Stinson E. B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982 Jul 22;307(4):205–211. doi: 10.1056/NEJM198207223070401. [DOI] [PubMed] [Google Scholar]
  3. Duhamel R. C., Meezan E., Brendel K. The addition of SDS to the Bradford dye-binding protein assay, a modification with increased sensitivity to collagen. J Biochem Biophys Methods. 1981 Aug;5(2):67–74. doi: 10.1016/0165-022x(81)90007-5. [DOI] [PubMed] [Google Scholar]
  4. Ferguson S. S., Zhang J., Barak L. S., Caron M. G. G-protein-coupled receptor kinases and arrestins: regulators of G-protein-coupled receptor sequestration. Biochem Soc Trans. 1996 Nov;24(4):953–959. doi: 10.1042/bst0240953. [DOI] [PubMed] [Google Scholar]
  5. Gaudin C., Ishikawa Y., Wight D. C., Mahdavi V., Nadal-Ginard B., Wagner T. E., Vatner D. E., Homcy C. J. Overexpression of Gs alpha protein in the hearts of transgenic mice. J Clin Invest. 1995 Apr;95(4):1676–1683. doi: 10.1172/JCI117843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harden T. K. Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev. 1983 Mar;35(1):5–32. [PubMed] [Google Scholar]
  7. Hoit B. D., Khoury S. F., Kranias E. G., Ball N., Walsh R. A. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res. 1995 Sep;77(3):632–637. doi: 10.1161/01.res.77.3.632. [DOI] [PubMed] [Google Scholar]
  8. Iwase M., Bishop S. P., Uechi M., Vatner D. E., Shannon R. P., Kudej R. K., Wight D. C., Wagner T. E., Ishikawa Y., Homcy C. J. Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ Res. 1996 Apr;78(4):517–524. doi: 10.1161/01.res.78.4.517. [DOI] [PubMed] [Google Scholar]
  9. Iwase M., Uechi M., Vatner D. E., Asai K., Shannon R. P., Kudej R. K., Wagner T. E., Wight D. C., Patrick T. A., Ishikawa Y. Cardiomyopathy induced by cardiac Gs alpha overexpression. Am J Physiol. 1997 Jan;272(1 Pt 2):H585–H589. doi: 10.1152/ajpheart.1997.272.1.H585. [DOI] [PubMed] [Google Scholar]
  10. Kiuchi K., Shannon R. P., Komamura K., Cohen D. J., Bianchi C., Homcy C. J., Vatner S. F., Vatner D. E. Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest. 1993 Mar;91(3):907–914. doi: 10.1172/JCI116312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Krell M. J., Kline E. M., Bates E. R., Hodgson J. M., Dilworth L. R., Laufer N., Vogel R. A., Pitt B. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J. 1986 Oct;112(4):787–791. doi: 10.1016/0002-8703(86)90475-8. [DOI] [PubMed] [Google Scholar]
  12. Kudej R. K., Iwase M., Uechi M., Vatner D. E., Oka N., Ishikawa Y., Shannon R. P., Bishop S. P., Vatner S. F. Effects of chronic beta-adrenergic receptor stimulation in mice. J Mol Cell Cardiol. 1997 Oct;29(10):2735–2746. doi: 10.1006/jmcc.1997.0508. [DOI] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Lakatta E. G. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev. 1993 Apr;73(2):413–467. doi: 10.1152/physrev.1993.73.2.413. [DOI] [PubMed] [Google Scholar]
  15. Lamb T. D. Gain and kinetics of activation in the G-protein cascade of phototransduction. Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):566–570. doi: 10.1073/pnas.93.2.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lambertz H., Meyer J., Erbel R. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation. 1984 Feb;69(2):298–305. doi: 10.1161/01.cir.69.2.298. [DOI] [PubMed] [Google Scholar]
  17. Lefkowitz R. J., Stadel J. M., Caron M. G. Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. Annu Rev Biochem. 1983;52:159–186. doi: 10.1146/annurev.bi.52.070183.001111. [DOI] [PubMed] [Google Scholar]
  18. Metra M., Nardi M., Giubbini R., Dei Cas L. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1994 Dec;24(7):1678–1687. doi: 10.1016/0735-1097(94)90174-0. [DOI] [PubMed] [Google Scholar]
  19. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  20. Olsen S. L., Gilbert E. M., Renlund D. G., Taylor D. O., Yanowitz F. D., Bristow M. R. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol. 1995 May;25(6):1225–1231. doi: 10.1016/0735-1097(95)00012-S. [DOI] [PubMed] [Google Scholar]
  21. Oppermann M., Diversé-Pierluissi M., Drazner M. H., Dyer S. L., Freedman N. J., Peppel K. C., Lefkowitz R. J. Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7649–7654. doi: 10.1073/pnas.93.15.7649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Premont R. T., Inglese J., Lefkowitz R. J. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 1995 Feb;9(2):175–182. doi: 10.1096/fasebj.9.2.7781920. [DOI] [PubMed] [Google Scholar]
  23. Sahn D. J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978 Dec;58(6):1072–1083. doi: 10.1161/01.cir.58.6.1072. [DOI] [PubMed] [Google Scholar]
  24. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  25. Sato N., Kiuchi K., Shen Y. T., Vatner S. F., Vatner D. E. Adrenergic responsiveness is reduced, while baseline cardiac function is preserved in old adult conscious monkeys. Am J Physiol. 1995 Nov;269(5 Pt 2):H1664–H1671. doi: 10.1152/ajpheart.1995.269.5.H1664. [DOI] [PubMed] [Google Scholar]
  26. Sibley D. R., Lefkowitz R. J. Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature. 1985 Sep 12;317(6033):124–129. doi: 10.1038/317124a0. [DOI] [PubMed] [Google Scholar]
  27. Uechi M., Asai K., Osaka M., Smith A., Sato N., Wagner T. E., Ishikawa Y., Hayakawa H., Vatner D. E., Shannon R. P. Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsalpha. Circ Res. 1998 Mar 9;82(4):416–423. doi: 10.1161/01.res.82.4.416. [DOI] [PubMed] [Google Scholar]
  28. Vatner D. E. Characterization of subfractions from purified sarcolemma of canine left ventricle. J Mol Cell Cardiol. 1990 Dec;22(12):1349–1357. doi: 10.1016/0022-2828(90)90980-g. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES